Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc Stock
With only a change of -€0.200 (-0.090%) the Jazz Pharmaceuticals plc price is nearly unchanged from yesterday.
The stock is an absolute favorite of our community with 41 Buy predictions and no Sell predictions.
At the moment Jazz Pharmaceuticals plc has reached the predicted target price of 221 €, with a current price of 218.9 €.
Pros and Cons of Jazz Pharmaceuticals plc in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Jazz Pharmaceuticals plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | -0.090% | -2.538% | 2.818% | 119.207% | 51.593% | 85.587% | 52.225% |
| Repligen Corp. | 2.370% | 5.620% | 4.583% | 24.380% | -9.265% | -18.077% | -39.114% |
| Opko Health Inc. | 1.800% | 6.604% | -10.317% | 8.321% | 3.651% | -31.140% | -61.235% |
| China Traditional Chinese Medicine Co Ltd | 0.000% | 0.000% | 0.000% | -10.569% | 0.917% | -44.162% | -56.000% |
Comments
Jazz Pharmaceuticals (JAZZ) had its price target raised by Needham & Company LLC from $255.00 to $282.00. They now have a "buy" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) was upgraded by Canaccord Genuity Group Inc. to "strong-buy".
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) had its price target raised by Wells Fargo & Company from $265.00 to $285.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat